Page last updated: 2024-09-05

t-2 toxin and niacinamide

t-2 toxin has been researched along with niacinamide in 1 studies

Compound Research Comparison

Studies
(t-2 toxin)
Trials
(t-2 toxin)
Recent Studies (post-2010)
(t-2 toxin)
Studies
(niacinamide)
Trials
(niacinamide)
Recent Studies (post-2010) (niacinamide)
1,3451351313,3811,0975,797

Protein Interaction Comparison

ProteinTaxonomyt-2 toxin (IC50)niacinamide (IC50)
Chain A, NAD-dependent deacetylaseThermotoga maritima1000
Fatty-acid amide hydrolase 1Rattus norvegicus (Norway rat)3.3
NAD-dependent protein deacetylase sirtuin-2Homo sapiens (human)2.9
NAD-dependent protein deacetylase sirtuin-3, mitochondrialHomo sapiens (human)8.1

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berger, W; Dornetshuber-Fleiss, R; Heffeter, P; Heilos, D; Lemmens-Gruber, R; Mohr, T; Novicky, A; Richter, L; Süssmuth, RD; Zlesak, M1

Other Studies

1 other study(ies) available for t-2 toxin and niacinamide

ArticleYear
The naturally born fusariotoxin enniatin B and sorafenib exert synergistic activity against cervical cancer in vitro and in vivo.
    Biochemical pharmacology, 2015, Feb-01, Volume: 93, Issue:3

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Depsipeptides; Dose-Response Relationship, Drug; Drug Synergism; Female; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice; Mice, SCID; Niacinamide; Phenylurea Compounds; Sorafenib; T-2 Toxin; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays

2015